JULIE JABLONSKI: Open Payments
NPI 1396827739 · LENEXA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$730 in 31 payments from 5 companies in 2025. Trend: 2023 $1,194 · 2024 $869 · 2025 $730
Food & beverage: $730
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $255 |
| AstraZeneca Pharmaceuticals LP | 8 | $194 |
| Lilly USA, LLC | 7 | $147 |
| ABBVIE INC. | 5 | $103 |
| PFIZER INC. | 2 | $32 |
Products named: Ozempic, MOUNJARO, BREZTRI, AIRSUPRA, UBRELVY, Wegovy, VRAYLAR, PREVNAR 20.
Industry payments across KS — which companies pay providers there.
